共 16 条
[1]
DRUGS[P]. HIDAKA HIROYOSHI;TAKAGI MANABU;MATSUZAKI TAKUSHI.WO9964011A1,1999-12-16
[2]
Human immunodeficiency virus(HIV) Type 1 reverse transcriptase resistance mutation in hepatitis B virus(HBV)-HIV-coinfected patients treated for HBV chronic infection once daily with 10 milligrams of adefovir dipivoxil combined with lamivudine. Delaugerre C,Marcelin AG,Thibault V,Peytavin G,et al. Antimicrobial Agents and Chemotherapy . 2002
[3]
Antiviral efficacy and pharmaco- kinetics of oral adefovir dipivoxil in chronically woodchuck hepatitis virus-infected woodchucks. Cullen JM,Li DH,Brown C,et al. Antimicrobial Agents and Chemotherapy . 2001
[4]
Cytotoxicity of antiviral nucle-otides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. Ho ES,Lin DC,Mendel DB,et al. Journal of the American Society of Nephrology . 2000
[5]
Adefovir nephrotoxicity and mitochondrial DNA depletion. Bendele RA,Richardson FC. Human Pathology . 2002
[6]
Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants. Perrillo R. Schiff E.Yoshida E,et al. Hepatology . 2000
[7]
Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. Marcellin P,Chang TT,Lim SG,et al. The New England Journal of Medicine . 2003
[8]
Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. Hadziyannis SJ,Tassopoulos NC,Heathcote EJ,et al. The New England Journal of Medicine . 2003
[9]
Inhibition of duck hepatitis B virus replication by 9-(2-phosphonylmethoxyethyl) adenine, an acryclic phosphonate nucleoside analogue. Nicoll AJ,Colledge DL,Toole JJ,et al. Antimicrobial Agents and Chemotherapy . 1998
[10]
A placebo-controlled phase I/ II study of adefovir dipivoxil in patients with chronic hepatitis B virus infection. Gilson R,Chopra K,Newell A,et al. Journal of Viral Hepatitis . 1999